Here's Why Longeveron Stock Jumped Higher on Wednesday
Shares of Longeveron (NASDAQ: LGVN), a clinical-stage biopharmaceutical company, jumped more than 25% higher when the stock market opened. Investors eager to cash in on the next possible Alzheimer's drug were responsible for the bounce, which quickly began losing steam. Longeveron's stock price was 10.8% higher at 11:50 a.m. ET on Wednesday.
This morning, Longeveron announced the initiation of a phase 2 trial that will eventually enroll 48 patients with Alzheimer's disease.
Source Fool.com